GlassScriptPhysician profile
Alejandro Trujillo
NPI 1528553856
$1,468.44
in general payments reported to CMS, 2019-2025
10 companies · $886 in 2025
The $886 reported for 2025 was more than what 90% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.90 · 2020: $32.81 · 2022: $20.87 · 2023: $209 · 2024: $284 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351 · Education: $27.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.31 |
| Education | $27.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $636.42 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $254.37 | 2022-2025 | Ozempic, Rybelsus |
| Amgen INC. | $186.24 | 2024-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $107.25 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $104.08 | 2024-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $50.89 | 2025 | The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $44.71 | 2024 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.81 | 2020 | |
| Medtronic, INC. | $15.77 | 2025 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Trujillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.